Identification of CD8+ T cell epitopes through proteasome cleavage site predictions

Abstract

Background We previously introduced PCPS (Proteasome Cleavage Prediction Server), a web-based tool to predict proteasome cleavage sites using n-grams. Here, we evaluated the ability of PCPS immunoproteasome cleavage model to discriminate CD8+ T cell epitopes. Results We first assembled an epitope dataset consisting of 844 unique virus-specific CD8+ T cell epitopes and their source proteins. We then analyzed cleavage predictions by PCPS immunoproteasome cleavage model on this dataset and compared them with those provided by a related method implemented by NetChop web server. PCPS was clearly superior to NetChop in term of sensitivity (0.89 vs. 0.79) but somewhat inferior with regard to specificity (0.55 vs. 0.60). Judging by the Mathew’s Correlation Coefficient, PCPS predictions were overall superior to those provided by NetChop (0.46 vs. 0.39). We next analyzed the power of C-terminal cleavage predictions provided by the same PCPS model to discriminate CD8+ T cell epitopes, finding that they could be discriminated from random peptides with an accuracy of 0.74. Following these results, we tuned the PCPS web server to predict CD8+ T cell epitopes and predicted the entire SARS-CoV-2 epitope space. Conclusions We report an improved version of PCPS named iPCPS for predicting proteasome cleavage sites and peptides with CD8+ T cell epitope features. iPCPS is available for free public use at https://imed.med.ucm.es/Tools/pcps/.

Discovery of prevalent, clinically actionable tumor neoepitopes via integrated biochemical and cell-based platforms

“…Following development of a C1R HLAnull cell population, synthesis and delivery of piggyBac expression vectors enabled stable transgene integration. Local sequence context has the potential to affect antigen processing (Gomez-Perosanz et al, 2020), and to address this possibility we generated two foundational cell lines that co-expressed mutated sequences (∼25 amino acids) for all 47 prioritized neoantigens in distinct configurations ( Figure 3B ). These two cell lines differed by the presence or absence of short amino acid linker sequences between most neoantigen segments within the polyantigen cassette; hereafter referred to as linker and no-linker cell lines, respectively ( Figure 3B ).…”

Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation

“…NetChop enhances the specificity of binding predictions ( 81 ). A newer model, the Proteasome Cleavage Prediction Server (PCPS), demonstrated enhanced sensitivity (0.89 vs. 0.79), but diminished specificity (0.55 vs. 0.60), compared to NetChop for discriminating known CD8+ T cell epitopes from random peptides ( 82 ). While these results are not sufficient to recommend proteasomal cleavage as an independent metric for immunogenicity, they indicate that proteasomal C-terminal cleavage may play a role in determining the neoantigen profile.…”

T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy

“…Proteasomal processing prediction algorithms, such as Proteasome Cleavage Prediction Server (PCPS), SpliceMet and those offered by IEDB, can be used in conjunction with MHC prediction tools to more faithfully predict antigen presentation by MHC molecules and to identify potential sets of personalized tumor antigens using somatic mutations as inputs (61)(62)(63). Ultimately, although these tools are unable to predict T cell reactivity, they do tend generally determine the stability of the formed MHC/peptide complex, which contributes to its half-life and likelihood of being seen by any given T cell receptor.…”